Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 6Carcinoma, Hepatocellular 5Prostatic Neoplasms 3Liver Neoplasms 3Kidney Neoplasms 3Head and Neck Neoplasms 2Thyroid Neoplasms 1Sleep Apnea, Obstructive 1Sarcoma 1Rhinitis, Allergic, Seasonal 1Renal Insufficiency, Chronic 1Recurrence 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Ovarian Neoplasms 1Mesothelioma 1Melanoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hypertension, Pulmonary 1Emphysema 1Cystic Fibrosis 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Bronchiectasis 1Asthma 1Asbestosis 1

Interventions

Cisplatin 253Radiotherapy 176Cetuximab 145pembrolizumab 120Docetaxel 97Fluorouracil 92Carboplatin 80Paclitaxel 77Radiotherapy, Intensity-Modulated 69Nivolumab 37Radiation 30Drug Therapy 30Erlotinib Hydrochloride 26Gemcitabine 25Cyclophosphamide 22Gefitinib 21Surveys and Questionnaires 20Standard of Care 20Surgical Procedures, Operative 19Pemetrexed 19durvalumab 18Magnetic Resonance Spectroscopy 17Capecitabine 17Radiosurgery 16Celecoxib 16atezolizumab 15Filgrastim 15Amifostine 15130-nm albumin-bound paclitaxel 15fludarabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Head and Neck Neoplasms × perflutren × Clear all
NCT07501650 2026-03-30

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Thomas Jefferson University

Phase 1 Recruiting
6 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence

NCT04431648 2023-12-13

USmBRT-H

Sunnybrook Health Sciences Centre

Phase 1 Unknown
20 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡